Metformin and epithelial ovarian cancer therapeutics.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 365, doi. 10.1007/s13402-015-0235-7
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2015 AND VI 38 AND IP 5
Results: 7
1
2
NF-κB signaling in cancer stem cells: a promising therapeutic target?
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 327, doi. 10.1007/s13402-015-0236-6
- By:
- Publication type:
- Article
3
Methylation biomarkers for pleomorphic lobular breast cancer - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 397, doi. 10.1007/s13402-015-0241-9
- By:
- Publication type:
- Article
4
Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 377, doi. 10.1007/s13402-015-0237-5
- By:
- Publication type:
- Article
5
Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 387, doi. 10.1007/s13402-015-0238-4
- By:
- Publication type:
- Article
6
Anti-tumor effect of emodin on gynecological cancer cells.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 353, doi. 10.1007/s13402-015-0234-8
- By:
- Publication type:
- Article
7
MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells.
- Published in:
- Cellular Oncology (2211-3428), 2015, v. 38, n. 5, p. 341, doi. 10.1007/s13402-015-0233-9
- By:
- Publication type:
- Article